Arcus Biosciences, Inc. (RCUS)

Arcus Biosciences Revenue

Arcus Biosciences had revenue of $237.00M in the twelve months ending March 31, 2024, with 99.16% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $145.00M with 480.00% year-over-year growth. In the year 2023, Arcus Biosciences had annual revenue of $117.00M with 4.46% growth.

• Revenue (ttm): $237.00M
• Revenue Growth: +99.16%
• P/S Ratio: 5.48
• Revenue / Employee: $410,745
• Employees: 577
• Market Cap: 1.30B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	117.00M	5.00M	4.46%
Dec 31, 2022	112.00M	-271.00M	-70.76%
Dec 31, 2021	383.00M	305.00M	391.03%
Dec 31, 2020	78.00M	63.00M	420.00%
Dec 31, 2019	15.00M	6.65M	79.58%
Dec 31, 2018	8.35M	6.94M	491.15%
Dec 31, 2017	1.41M	-	-
Dec 31, 2016	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.